MapLight Therapeutics, Inc.
MPLT
$13.63
$0.644.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.60% | -11.02% | 0.00% | -9.36% | 2.83% |
| Total Depreciation and Amortization | -18.07% | -12.86% | 0.00% | 10.12% | 17.69% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 450.90% | 215.97% | 0.00% | -130.19% | -49.26% |
| Change in Net Operating Assets | -46.08% | -495.63% | 0.00% | -372.94% | 110.42% |
| Cash from Operations | -32.94% | -23.60% | 0.00% | -17.90% | 12.08% |
| Capital Expenditure | -- | -- | 0.00% | 16.67% | -14,300.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.33% | 80.66% | 0.00% | 117.08% | -- |
| Cash from Investing | -53.51% | 82.78% | 0.00% | 116.84% | -6,090,900.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -40.00% | -65.52% | 0.00% | -94.44% | 6,425.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -205.77% | 54.98% | 0.00% | 94.10% | -- |
| Cash from Financing | -231.91% | 53.47% | 0.00% | 94.05% | -101.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -240.21% | 4,767.84% | 0.00% | 99.82% | -241.03% |